CLEVELAND, Ohio - Simbionix USA Corporation, the world’s leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM).
The new Laparoscopic Essential Tasks Module is an addition to the LAP Mentor’s ever-expanding library of modules. This new module takes hands-on skill training another step forward, enabling the trainee to practice three essential tasks, similar to the Fundamentals of Laparoscopic Surgery Program (FLS) developed by SAGES.
“The module is a breakthrough technology that provides an efficient and exciting virtual reality environment,” explains Simbionix President Ran Bronstein.
During the same week, Simbionix released a new, enhanced version of the PROcedure Rehearsal Studio(TM), marking another important advance in its innovative simulation technology.
This unique product, previously introduced by Simbionix last year, is the world’s first medical simulator to enable clinicians to create practice scenarios based on their patient’s unique anatomy as reconstructed from CT data.
Inbal Mazor, Simbionix Vice President of Corporate Marketing, adds:”This week’s release of the PROcedure Rehearsal Studio with the PACS-enabled capability allows for a wide range of scans and enables the sharing of training cases for educational use. With this new version, the system is now more efficient, easier to use and extremely reliable. We are extremely proud of this new product, which will undoubtedly benefit both patient and clinicians.”
Simbionix will present these new releases at upcoming US medical tradeshows this fall: The PROcedure Rehearsal Studio on September 23rd at TCT 2009 in San Francisco and the new Laparoscopic Essential Tasks on Oct 12th at the ACS 2009 annual meeting.
About Simbionix USA Corporation
Simbionix is the leader in the development and delivery of innovative and effective virtual reality simulation products and solutions for clinical education and training of medical professionals. The products are designed to accelerate best-practice medical training, advance clinical performance, and improve patient safety.
The Simbionix product line includes the ANGIO Mentor(TM) line for endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and the URO Mentor(TM) for urological procedures. In addition, Simbionix distributes the HystSim(TM) for hysteroscopic procedures. Each simulation platform is a leading simulator in the relevant clinical area.
Simbionix simulation products have been validated in several scientific studies and the company cooperates closely with both industry and leading medical institutions to develop the most advanced simulators for the training and assessment of medical professionals.
www.simbionix.com
Contact: Galia Zilbershtein-Salant Exhibition Manager Simbionix Tel : +1-216-229-2040 galia@simbionix.com
Source: Simbionix Ltd.
Contact: Galia Zilbershtein-Salant, Exhibition Manager, Simbionix, Tel : +1-216-229-2040, galia at simbionix.com
Related Press Releases
Approval of Instanyl(R) Marks Important Turn in Management of Breakthrough Cancer PainJuly 23rd, 2009 TAASTRUP, Denmark -
- First Intranasal Treatment for Breakthrough Cancer Pain Allowing Patients Fast, Effective and Good Tolerated Pain Relief Soon to be Available
Nycomed today announced that the European Commission has granted marketing authorisation for Instanyl, its first-in-class intranasal fentanyl spray designed to closely match the typical episodes of breakthrough cancer pain. "We have had a great unmet need in the management of breakthrough cancer pain.
Simbionix Signs Agreement With the European Association for Endoscopic SurgeryJune 29th, 2009 PRAGUE - Prague Convention Center - Simbionix and the European Association for Endoscopic Surgery (EAES) have signed an agreement to collaborate on the development of training materials and assessment tools for a new Laparoscopic Skills Curriculum. Since its founding in 1990, the EAES has played a leading role in the promotion and dissemination of endoscopic surgery and allied interventional techniques throughout Europe.
Texert Acquires Anomaly Detection Technology From GEJune 23rd, 2009 DALLAS -
- Multiple-industry application identifies patterns of significance from minimal data sets to enable early warning risk detection and intelligent risk aware management for the Enterprise
The human eye cannot recognize the anomaly you just read. Every seventh word in this press release could be one one-hundredth smaller than every other word.
Senetek PLC Investor Hotline Goes LiveMay 14th, 2009 NAPA, California - Call +1-877-SENETEK or +1-707-259-6278
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced that an up-to-date audio recording of Company news and developments is now available by calling +1-877-SENETEK in the United States and Canada and +1-707-259-6278 from international locations. "We are pleased to provide this service to our investors as a supplement to news releases, shareholder teleconferences and our quarterly and annual filings.
Simbionix and B-Line Medical(R) Announce Multi-Level AgreementMay 4th, 2009 CLEVELAND Ohio, and WASHINGTON DC - Simulation Technology Leader and the Leading Developer of Simulation-based Healthcare Training Platforms Form Cooperative Agreement
Simbionix USA Corporation and B-Line Medical, LLC, today announced a strategic agreement enabling the data integration of Simbionix Mentor(TM) simulation systems with B-Line Medical's SimCapture(R) product. The collaboration will combine Simbionix' unique data collected during a simulation session with video streams into the SimCapture system for debriefing, assessing and centralizing multiple types of simulated encounters.
Plastipak Packaging Announces Breakthrough Hot-Fill Lightweighting Technology Deal with Tecsor HRApril 22nd, 2009 PLYMOUTH, Michigan - Plastipak Packaging, Inc. ("Plastipak"), a wholly owned subsidiary of Plastipak Holdings, Inc., is pleased to announce that it has entered into a perpetual and exclusive worldwide hot-fill technology license with Tecsor HR, a French corporation.
Caustic Reinvents Raytracing for Interactive, Cinema-Quality 3D GraphicsApril 19th, 2009 SAN FRANCISCO - Company Releases Caustic RT - Flexible Development Platform for No-Compromise Raytracing
Today Caustic Graphics released CausticRT(TM), the worlds only massively accelerated raytracing system for achieving breakthrough levels of quality in interactive, cinema-quality 3D computer graphics. The Caustic development platform, which includes a raytracing accelerator card and SDK, are now available to qualified developers so they can create new or port their existing 3D applications to Caustic and deliver fast, efficient raytracing to their customers.
Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS CountriesApril 16th, 2009 CLEVELAND, Ohio - Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries.
Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS CountriesApril 15th, 2009 CLEVELAND, Ohio - Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson.
Simbionix Increases Product Offerings for OB/GYN PhysiciansMarch 10th, 2009 CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery
- The New VirtaMed HystSim(TM) Simulator Adds Hysteroscopy to Simbionix'
Impressive Line of Medical Simulation and eLearning Products
Simbionix, the world's leading developer of medical simulation systems,
and VirtaMed, a Swiss medical engineering company, announced today a global
collaboration agreement. Simbionix will exclusively distribute, market, and
provide service for the VirtaMed HystSim, an advanced virtual reality
hysteroscopy simulator.
Related News
'Tata group innovating affordable products for masses'May 27th, 2009 BANGALORE - As part of its commitment to address the lower part of the pyramid, the Rs.150,000-crore Tata group is innovating affordable products for the masses, its chairman Ratan Tata said here Wednesday. "We have taken a conscious decision to innovate products that are affordable for the masses, which account for about 70 percent of our population," Tata told students of the premier Indian Institute of Science (IISc) here.
Earnings schedule for week of 8/17/09August 13th, 2009 Earnings schedule for week of 8/17/09Major companies tentatively scheduled to report quarterly earnings next week:
Monday
MOORESVILLE, N.C. — Lowe's Cos.
Pawar calls for innovative technologies to face complex problems in farming sectorJuly 16th, 2009 NEW DELHI - Union Agriculture Minister Sharad Pawar today cautioned farm scientists against complacency and reminded them that agriculture was faced with much more complex problems than before. Addressing scientists at the foundation day of the Indian Council of Agricultural Research (ICAR) here today, Pawar said, 'Agriculture today is faced with much more complex problems of climate change, decreasing efficiency of input and new emerging issues of world trade.
Calendar of major business events scheduled TuesdaySeptember 21st, 2009 Major business events scheduled TuesdayMajor business events and economic events scheduled for Tuesday:
WASHINGTON — Federal Housing Finance Agency releases July home price index, 10 a.m. WASHINGTON — Federal Open Market Committee meets for first day of two-day meeting.
Obama remark on Bangalore worrying, admits Azim PremjiMay 7th, 2009 BANGALORE - Terming the US President Barack Obama's tax reform proposal as a 'worrying' development, Wipro chairman Azim Premji Thursday said it was against what Obama said at the recent G-20 summit. 'It's worrying! This is against what Obama said at G-20 summit in London recently,' Premji told reporters here on the sidelines of the launch of Wipro's product qualification and compliance certificate facility 'Tarang'.
Earnings schedule for week of 05/04/09April 30th, 2009 Earnings schedule for week of 05/04/09Major companies tentatively scheduled to report quarterly earnings next week:
Monday:
CINCINNATI — The E.W. Scripps Co. releases first-quarter financial results.
Major companies tentatively scheduled to report earnings for week of 8/3/09July 30th, 2009 Earnings schedule for week of 8/3/09Major companies tentatively scheduled to report quarterly earnings next week:
Monday
THE WOODLANDS, Texas — Anadarko Petroleum Corp. releases second-quarter financial results.
Tata's Indian Hotels, Godrej among world 'unsung' innovatorsApril 12th, 2009 WASHINGTON - Five Indian companies led by Tata Group's Indian Hotels, Godrej Industries and Yes Bank figure in the list of the world's 25 'unsung' innovative companies by BusinessWeek magazine. The other Indian firms on the list are Bajaj Holdings & Investment and Bata India.
Russian president orders prosecutors to look into state corporations' financesAugust 7th, 2009 Medvedev wants state companies' finances checkedMOSCOW — President Dmitry Medvedev on Friday ordered prosecutors to look into the finances of state-owned corporate giants, which control some of Russia's major industrial companies and have been accused of inefficiency. The president ordered prosecutors to carry out a thorough investigation into the state corporations' activities and finances and consider whether such management forms are justified, the Kremlin said in a statement.
NASA announces green aircraft challengeAugust 2nd, 2009 WASHINGTON - The NASA Innovative Partnerships Program and the Comparative Aircraft Flight Efficiency (CAFE) Foundation have announced the Green Flight Challenge, which is a flight efficiency competition for aircraft that can average at least 100 mph on a 200-mile flight while achieving greater than 200 passenger miles per gallon. The prize for the aircraft with the best performance is 1.5 million dollars.
